ArticleJournal of the American Heart Association2022

Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA-AF Registry.

Wern Yew Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.